ABBOTT PARK, Ill., Dec. 13 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) announced today that it has acquired a majority of the shares of Kos Pharmaceuticals, Inc. (NASDAQ:KOSP). Abbott's cash...
ABBOTT PARK, Ill., Dec. 4 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) announced today that the Federal Trade Commission has granted early termination of the waiting period under the...
ABBOTT PARK, Ill., Nov. 14 /PRNewswire-FirstCall/ -- Abbott Laboratories (NYSE:ABT) today announced the commencement of its cash tender offer for all outstanding shares of common stock of Kos...
Kos Pharmaceuticals, Inc. (Nasdaq: KOSP): Third Quarter 2006 Financial Highlights+ Third quarter revenue increased 17% to a record $240.9 million Net income...
NEW YORK, Nov. 7 /PRNewswire/ -- Holland & Knight LLP announces the representation, along with Cravath, Swaine and Moore, of its client Kos Pharmaceuticals, Inc. (NASDAQ:KOSP) in the sale of Kos...
- Acquisition Strengthens Abbott's Late-Stage Pipeline - ABBOTT PARK, Ill. and CRANBURY, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) and Kos Pharmaceuticals, Inc. (NASDAQ:KOSP)today...
Kos Pharmaceuticals, Inc. (Nasdaq:KOSP), a fully integrated specialty pharmaceutical company, will announce results for the third quarter ended September 30, 2006, before the...
Kos Pharmaceuticals, Inc. (Nasdaq:KOSP): ? -- Efficacy data for FAST-2 meets primary endpoint, FAST-1 and FAST-2 combined analysis demonstrates a reduction in time to onset of symptom...
Kos Pharmaceuticals, Inc. (Nasdaq:KOSP) today announced that Adrian Adams, President and Chief Executive Officer, will present at the UBS Global Life Sciences Conference, which is being...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.